Literature DB >> 22209268

Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?

Salvatore Brugaletta1, Maria D Radu, Hector M Garcia-Garcia, Jung Ho Heo, Vasim Farooq, Chrysafios Girasis, Robert-Jan van Geuns, Leif Thuesen, Dougal McClean, Bernard Chevalier, Stephan Windecker, Jacques Koolen, Richard Rapoza, Karine Miquel-Hebert, John Ormiston, Patrick W Serruys.   

Abstract

OBJECTIVE: To quantify the circumferential healing process at 6 and 12 months following scaffold implantation.
BACKGROUND: The healing process following stent implantation consists of tissue growing on the top of and in the space between each strut. With the ABSORB bioresorbable vascular scaffold (BVS), the outer circumference of the scaffold is detectable by optical coherence tomography (OCT), allowing a more accurate and complete evaluation of the intra-scaffold neointima.
METHODS: A total of 58 patients (59 lesions), who received an ABSORB BVS 1.1 implantation and a subsequent OCT investigation at 6 (n=28 patients/lesions) or 12 (n=30 patients with 31 lesions) months follow-up were included in the analysis. The thickness of the neointima was calculated circumferentially in the area between the abluminal side of the scaffold and the lumen by means of an automated detection algorithm. The symmetry of the neointima thickness in each cross section was evaluated as the ratio between minimum and maximum thickness.
RESULTS: The neointima area was not different between 6 and 12 months follow-up (1.57±0.42 mm(2) vs. 1.64±0.77 mm(2); p=0.691). No difference was also found in the mean thickness of the neointima (median [IQR]) between the two follow-up time points (210 μm [180-260]) vs. 220 μm [150-260]; p=0.904). However, the symmetry of the neointima thickness was higher at 12 than at 6 months follow-up (0.23 [0.13-0.28] vs. 0.16 [0.08-0.21], p=0.019).
CONCLUSIONS: A circumferential evaluation of the healing process following ABSORB implantation is feasible, showing the formation of a neointima layer, that resembles a thick fibrous cap, known for its contribution to plaque stability. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209268     DOI: 10.1016/j.atherosclerosis.2011.12.008

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  32 in total

1.  Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.

Authors:  Michele Pighi; Fabrizio Tomai; Alessandro Petrolini; Leonardo de Luca; Giuseppe Tarantini; Alberto Barioli; Paola Colombo; Silvio Klugmann; Marco Ferlini; Maurizio Ferrario Ormezzano; Bruno Loi; Paolo Calabrò; Renato Maria Bianchi; Giuseppe Faggian; Alberto Forni; Corrado Vassanelli; Marco Valgimigli; Flavio Ribichini
Journal:  J Cardiovasc Transl Res       Date:  2015-12-18       Impact factor: 4.132

2.  Implications of a bioresorbable vascular scaffold implantation on vessel wall strain of the treated and the adjacent segments.

Authors:  Christos V Bourantas; Hector M Garcia-Garcia; Carlos A M Campos; Yao-Jun Zhang; Takashi Muramatsu; Marie-Angèle Morel; Shimpei Nakatani; Xingyu Gao; Yun-Kyeong Cho; Yuki Isibashi; Frank J H Gijsen; Yoshinobu Onuma; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-24       Impact factor: 2.357

3.  Effect of strut distribution on neointimal coverage of everolimus-eluting bioresorbable scaffolds: an optical coherence tomography study.

Authors:  Takao Sato; John Jose; Abdelhakim Allai; Mohamed El-Mawardy; Ralph Tölg; Gert Richardt; Mohamed Abdel-Wahab
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

Review 4.  A review of bioresorbable scaffolds: hype or hope?

Authors:  Huay Cheem Tan; Rajiv Ananthakrishna
Journal:  Singapore Med J       Date:  2016-11-21       Impact factor: 1.858

Review 5.  Imaging strategies for tissue engineering applications.

Authors:  Seung Yun Nam; Laura M Ricles; Laura J Suggs; Stanislav Y Emelianov
Journal:  Tissue Eng Part B Rev       Date:  2014-08-19       Impact factor: 6.389

Review 6.  Use of intravascular imaging in managing coronary artery disease.

Authors:  Sanda Jegere; Inga Narbute; Andrejs Erglis
Journal:  World J Cardiol       Date:  2014-06-26

7.  The impact of Fourier-Domain optical coherence tomography catheter induced motion artefacts on quantitative measurements of a PLLA-based bioresorbable scaffold.

Authors:  N S van Ditzhuijzen; A Karanasos; N Bruining; M van den Heuvel; O Sorop; J Ligthart; K Witberg; H M Garcia-Garcia; F Zijlstra; D J Duncker; H M M van Beusekom; E Regar
Journal:  Int J Cardiovasc Imaging       Date:  2014-05-16       Impact factor: 2.357

Review 8.  The effects of novel, bioresorbable scaffolds on coronary vascular pathophysiology.

Authors:  Michael J Lipinski; Ricardo O Escarcega; Thibault Lhermusier; Ron Waksman
Journal:  J Cardiovasc Transl Res       Date:  2014-05-07       Impact factor: 4.132

Review 9.  Invasive coronary imaging: any role in primary and secondary prevention?

Authors:  Carlo Di Mario; Pedro R Moreno
Journal:  Eur Heart J       Date:  2016-03-21       Impact factor: 29.983

Review 10.  Bioresorbable Polymers and Stent Devices.

Authors:  Payam Dehghani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.